Genvira and NRC were Highlighted for their Collaborative Project Announcement Genvira Biosciences Inc., a pioneering Canadian innovator in viral vectors, LabSkin Limited, a global leader in 3D in vitro human skin models, and the National Research Council of Canada (NRC) will be introducing a c...
Silexion’s Robust Preclinical Data Dhowed Excellent Results Announcement Silexion Therapeutics Corp., a global clinical-stage biotechnology company developing RNA interference (RNAi) therapies for KRAS-targeted cancers, revealed excellent new preclinical data results, stating the inhibit...
Zenara’s Final Approval for its New Capsules Announcement Zenara Pharma Private Limited, a pioneering biophore company, finally received approval from the FDA for its abbreviated new drug application (ANDA) named Sertraline Hydrochloride Capsules (SHC), 150 mg and 200 mg. It is the first...
Azenta and Frenova’s Partnership to Advance Genomic Research in Nephrology Announcement Frenova, a division of Fresenius Nephronomics and Medical Care, a renal precision medicine company, and Azenta Inc. entered into a partnership to head start with data generation for Frenova’s tr...
According to Precedence Research, the global in-vitro inflammatory bowel disease diagnostics market size is expected to be worth around USD 3.02 billion in 2034, increasing from USD 1.84 billion in 2025. The market is poised to grow at a CAGR of 4.9% from 2025 to 2034. In-Vitro Inflammatory Bowel...
Alafair BioSceinces Received Confirmation for Versacoat™ Nerve Protector and Versacoat™ Tendon Protector Announcement Alafair Biosciences, a well-established medical device company reshaping soft-tissue protection in orthopedic surgery, received a 510 (k) clearance from the FDA for...
Moderna’s Updated COVID-19 Vaccine Received Approval from the European Commission Announcement Moderna Inc. received a commercial authorization from the European Commission on the updated formulation of the COVID-19 vaccine known as Spikevax, focusing on the SARS-CoV-2 variant Lp 8.1 for...
W Health Ventures Funded Millions to Develop Healthcare Innovation in India Announcement W Health Ventures has raised a $70 million fund for the second time to help healthcare startups build from scratch. This valuable initiative reflects the firm’s commitment to the next-generation of h...
Xenetic and Periness Signed a ‘Clinical Study Agreement’ Announcement Xenetic Biosciences Inc., a leading biopharmaceutical company focused on developing and advancing innovative immune-oncology technologies, identifying treatments for cancer patients, partnered with Periness Ltd. ...
Natera Introduces ABCSG 61’s TEODOR Trial Announcement Natera Inc., a well-known leader in cell-free DNA and precision medicine, has begun a new TEODOR trial, a neoadjuvant treatment optimization featured by ctDNA and endocrine responsiveness. The TEODOR is a phase 2 multicenter, randomi...
